中文

← All funding rounds

BioMap

ChinaScience models and AI scientistsBeijing (R&D centres in Silicon Valley, Suzhou and Hong Kong), ChinaFounded 2020IPO filed

Website · biomap.com ↗

Builds xTrimo, large life-science foundation models over protein, DNA and RNA data, and sells models and discovery work to drugmakers such as Sanofi.

Bloomberg reported on 2026-03-16 that BioMap confidentially filed for a Hong Kong IPO with CICC, Morgan Stanley and UBS; the company has not confirmed, and no prospectus is public.

Disclosed total-
Rounds on record2
Latest roundamount not disclosedRound (unnamed) · 2024-06-24
Last stated valuationNone stated
Investors named4
Research on record1highest level 2 · Computed

Money and evidence

Moneyeach round in US dollars; ≈ converted at its date20222023202420252026Series ARound (unnamed)Evidencelevel of each research entry12345
Closed roundNot on the dollar scale (a range, or no rate)Research entry, at its level

Latest round, Round (unnamed), 2024-06-24: the record then held no research entry for the company. The first research entry is dated 2025-04-03; the highest level so far is 2 (Computed).

Rounds and research, on one timeline

  1. 2025-04-03
    Research

    Level 2 · Computed

    BioMap's xTrimoPGLM, a 100-billion-parameter protein language model, both reads and writes protein sequences, its authors report in Nature Methods

    Most protein language models were trained either to fill in sequences, which suits reading them, or to write them letter by letter, which suits making them, and the authors say that left them struggling to do both. This paper shows one model doing both, at a size the authors call unprecedented, and it is BioMap's main peer-reviewed model paper. The weights and the downstream datasets are public on Hugging Face.

    Timeline entry →doi.org ↗

  2. 2024-06-24Round (unnamed)
    Round

    amount not disclosed

    For: strategic tie with HKIC: Hong Kong innovation hub, conferences, talent, priority on a Hong Kong listing

    Commercial roll-out

    HKIC announced it would lead; later reports say the amount was never disclosed. The company told TMTPost in 2024 it had raised over $200M in total.

    Lead · Hong Kong Investment Corporation ✓

    On the deal: Jiaqi Chen (CEO, Hong Kong Investment Corporation)

    The investor's own page says · Hong Kong Investment Corporation: 2024-06

    Announced by the company · jiemian.com ↗

  3. 2021-07Series A
    Round

    over US$100 million

    For: technology R&D and hiring, building out its bio-computing engine

    Models and platformHiring

    Lead not named; the 2021 announcement itself was not read. Use of funds from PEdaily, 2021-07-30.

    GGV CapitalBaiduRobin Li (founder, added)

    Reported by Yicai · yicai.com ↗

Research entries are the timeline's graded entries that name this company. A level grades one claim, not the company, and a blank can mean the record has not caught up rather than that nothing was published.

See these rounds in the table →

On the investors' own sites

Investors that name this company on their own site, in a portfolio or their own announcement. A ✓ in a round marks the same investor.

Other backers, round not stated

Named as backers in investor databases, reports or the investors' own posts; no source read places them in a round on the record.

Xianghe Capital